Balchem Corp. (NASDAQ:BCPC) Director Dino A. Rossi sold 16,400 shares of the company’s stock in a transaction on Friday, October 7th. The stock was sold at an average price of $78.57, for a total transaction of $1,288,548.00. Following the sale, the director now directly owns 23,248 shares of the company’s stock, valued at approximately $1,826,595.36. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Shares of Balchem Corp. (NASDAQ:BCPC) opened at 78.22 on Friday. The company has a 50 day moving average of $70.77 and a 200-day moving average of $64.16. Balchem Corp. has a one year low of $53.11 and a one year high of $79.49. The stock has a market cap of $2.47 billion, a price-to-earnings ratio of 44.44 and a beta of 0.61.

Balchem Corp. (NASDAQ:BCPC) last issued its quarterly earnings results on Friday, August 5th. The company reported $0.44 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.65 by $0.21. Balchem Corp. had a return on equity of 16.85% and a net margin of 10.18%. The company had revenue of $138.80 million for the quarter, compared to analyst estimates of $134.77 million. On average, analysts anticipate that Balchem Corp. will post $2.57 earnings per share for the current year.

Insider Buying and Selling by Quarter for Balchem Corp. (NASDAQ:BCPC)

Separately, Pivotal Research reissued a “hold” rating and issued a $65.00 price objective on shares of Balchem Corp. in a report on Sunday, August 7th.

About Balchem Corp.

Balchem Corporation (Balchem) is engaged in the development, manufacture, distribution and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical and medical sterilization industries. The Company operates in four segments: SensoryEffects, Animal Nutrition & Health (ANH), Specialty Products and Industrial Products.

5 Day Chart for NASDAQ:BCPC

Receive News & Ratings for Balchem Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem Corp. and related companies with's FREE daily email newsletter.